Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Jul;10(Suppl 18):S2106-S2108.
doi: 10.21037/jtd.2018.06.55.

Dual antiplatelet therapy post CABG?-perhaps, but… why not a radial artery instead?

Jeremy R Leonard  1 , Antonino Di Franco  1 , Mario Gaudino  1
Affiliations
Editorial

Dual antiplatelet therapy post CABG?-perhaps, but… why not a radial artery instead?

Jeremy R Leonard et al. J Thorac Dis. 2018 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

References

    1. Zhao Q, Zhu Y, Xu Z, et al. Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial. JAMA 2018;319:1677-86. 10.1001/jama.2018.3197 - DOI - PMC - PubMed
    1. Sipahi I, Akay MH, Dagdelen S, et al. Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention and Long-term Mortality and Morbidity in Multivessel Disease: Meta-analysis of Randomized Clinical Trials of the Arterial Grafting and Stenting Era. JAMA Intern Med 2014;174:223-30. 10.1001/jamainternmed.2013.12844 - DOI - PubMed
    1. Alexander JH, Hafley G, Harrington RA, et al. Efficacy and Safety of Edifoligide, an E2F Transcription Factor Decoy, for Prevention of Vein Graft Failure Following Coronary Artery Bypass Graft Surgery: PREVENT IV: A Randomized Controlled Trial. JAMA 2005;294:2446-54. 10.1001/jama.294.19.2446 - DOI - PubMed
    1. Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013;381:629-38. 10.1016/S0140-6736(13)60141-5 - DOI - PubMed
    1. Park SJ, Ahn JM, Kim YH, et al. Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease. N Engl J Med 2015;372:1204-12. 10.1056/NEJMoa1415447 - DOI - PubMed

LinkOut - more resources